Cardiac assessment of early breast cancer patients 18 years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy.

Background Epirubicin-based chemotherapy improves the outcome of early breast cancer (BC) patients. However, cardiotoxicity remains an important side effect. Methods We re-consented node-positive BC patients enrolled in a phase III trial between 1988 and 1996 which compared six cycles of oral cyclop...

Descripción completa

Detalles Bibliográficos

Publicado en:	European Journal of Cancer Vol. 51; no. 17; pp. 2517 - 2525
Autores principales:	de Azambuja, Evandro, Ameye, Lieveke, Diaz, Marie, Vandenbossche, Sandrine, Aftimos, Philippe, Hernández, Sara Bejarano, Shih-Li, Chao, Delhaye, François, Focan, Christian, Cornez, Nathalie, Vindevoghel, Anita, Beauduin, Marc, Lemort, Marc, Paesmans, Marianne, Suter, Thomas, Piccart-Gebhart, Martine
Formato:	clinical trial research Journal Article
Publicado:	Pergamon Press - An Imprint of Elsevier Science Nov2015
Acceso en línea:	Ver este registro en EBSCOhost